STAMBP and Keratoconjunctivitis sicca: Some studies have demonstrated that administration of α-MSH ameliorates ocular surface dysfunction and dry eye symptoms by decreasing proinflammatory cytokine levels through activating the PKA-extracellular signal–regulated kinase (ERK) pathway [223,226,227].